Publikasi Scopus FKUI Terkait Covid-19 Update 13 Desember 2021

Adiwinata Pawitan J.
6508348067;
Convalescent plasma for COVID-19 considerations
2021
Transfusion and Apheresis Science
60
1
102927
1
Department of Histology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Stem Cell Medical Technology Integrated Service Unit, Dr. Cipto Mangunkusumo General Hospital/Faculty of Medicine, Universitas Indonesia, Indonesia; Stem Cell and Tissue Engineering Research Center, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine Universitas Indonesia, Indonesia
Adiwinata Pawitan, J., Department of Histology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Stem Cell Medical Technology Integrated Service Unit, Dr. Cipto Mangunkusumo General Hospital/Faculty of Medicine, Universitas Indonesia, Indonesia, Stem Cell and Tissue Engineering Research Center, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine Universitas Indonesia, Indonesia
[No abstract available]
Convalescent plasma; COVID-19
immunoglobulin A; neutralizing antibody; oxyhemoglobin; SARS-CoV-2 convalescent plasma; adverse event; anaphylaxis; antibody titer; case study; China; coronavirus disease 2019; critically ill patient; cytokine storm; human; Letter; pilot study; transfusion related acute lung injury; treatment contraindication; virus virulence; Coronavirus infection; passive immunization; plasma; therapy; Coronavirus Infections; COVID-19; Humans; Immunization, Passive; Plasma; SARS-CoV-2
Elsevier Ltd
14730502
32878733
Letter
Q3
450
11031